ALMKT — Mauna Kea Technologies SA Share News
0.000.00%
- €18.03m
- €27.51m
- €8.22m
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus
Brief: Mauna Kea Technologies Granted 14th U.S. Patent For AI Enhancement Of CLE
Brief: Mauna Kea Technologies Announces Its Sales For Q2 2024
Europe Research Roundup: Asmi, Beiersdorf, SSE
Brief: Mauna Kea Technologies Executes Agreement To Restructure Its Existing Loan Agreement With European Investment Bank
Brief: Mauna Kea Technologies FY Sales Up 42% At EUR 10.5 Million
Brief: Telix Buys Around 19% Stake In Mauna Kea Technologies
Brief: Mauna Kea Technologies Q3 Sales Rise To EUR 1.5 Million
Brief: Mauna Kea Technologies Announces Positive Results From Interstitial Lung Disease Trial
Brief: Mauna Kea Technologies Says Transfer Of Its Shares On Euronext Growth Paris Market To Be Effective August 8, 2023
Brief: Mauna Kea Technologies Q2 Sales At EUR 2.68 Million
Brief: Mauna Kea Technologies: Start Of Enrollment In Peripheral Lung Cancer Multi-Site Clinical Trial
Brief: Mauna Kea Technologies: Financing Line With Vester Finance To Max 11.4% Of Capital
Brief: Mauna Kea Technologies Sas - Mauna Kea Technologies Reports 2022 Annual Results
Brief: Mauna Kea Technologies Q4 Sales Up 2% At EUR 2.7 Mln
Brief: Mauna Kea Technologies Announces Publication Of Results From First-In-Human Clinical Study For Lung Cancer